News
Mass Gen's Dr. Ali Raja explains why some were sent to the emergency room after using semaglutide injections. Raja says some of the symptoms people experienced won't require an ER visit. Raja says not ...
A major international study has found that semaglutide, a drug already used to treat type 2 diabetes and obesity, can ...
Novo Nordisk has pulled ahead in the race to bring the first oral GLP-1 for obesity to market. The company announced Friday ...
People with celiac disease had no problems after kissing a partner who'd just eaten a stack of saltine crackers, according to ...
21h
Pharmaceutical Technology on MSNFDA accepts Novo Nordisk’s NDA submission for weight management therapyThe US FDA has accepted Novo Nordisk’s new drug application (NDA) submission for the 25 mg oral formulation of Wegovy ...
AquaSculpt is a stimulant-free fat loss supplement getting attention in 2025 for its unique approach: triggering ...
We want you to take advantage of everything Clinical Advisor has to offer. To view unlimited content, log in or register for free.
16h
inews.co.uk on MSNInterest in weight-loss jabs is surging – here’s what semaglutide does to your bodyLast year, more than 16 million people googled 'semaglutide' - sold under the brand names Wegovy and Ozempic - as demand for ...
18h
NewsNation on MSNOzempic, Wegovy could reverse severe liver disease, study suggestsDrugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. The international study led by a Virginia Commonwealth University researcher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results